Home / News / Systagenix At Gargrave

Systagenix at Gargrave

Systagenix Logo

  Systagenix at Gargrave  

History of Gargrave Facility

 

  • 1780     Original woollen mill built

  • 1924     Johnson & Johnson Limited established in the U.K.

  • 1934     Gargrave site acquired by Johnson & Johnson

  • 1960     Research & Development presence established

  • 1973    Major facility extension

  • 1992     Cobalt sterilisation unit commissioned

  • 1995     Gargrave designated European Operations Centre

  • 1997    Specialist biopolymers R&D group relocate to Gargrave

  • 2003     U.S. A.W.C. & Biocides relocated to Gargrave

  • 2004     Freeze Drying facility is validated

  • 2007     New Technology Centre opens

  • 2008     Johnson & Johnson divest Professional Wound Care business and

  • Systagenix Wound Management established

  • 2009    Celebrating 75 years of Medical Device Manufacture


Total amount of major investments 2003 – 2009: $23.44MM

Gargrave Facility Workforce

  • Providing a broad range of skilled jobs in a rural economy

    • Manufacturing: 175

    • Engineering/Technology: 44

    • R&D, Regulatory & support functions: 112

    • Agency staff: 51

    • Total: 382

50 people with 25 years’ service & over

  • Supporting the local community

    • Community Action Group events

    • Supporting local charities

    • Supporting local schools and hospitals

  • Driving higher standard of care in the UK

    • One of the most penetrated markets in wound care

    • Gargrave continues to play a significant role

  • Sustaining UK’s strength in innovation

    • Centre of Excellence for Wound Healing



19 Nov 2010

Legal Notice Privacy Policy © Copyright 2016, 2018, KCI Licensing, Inc. All rights reserved.